BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Merlo LJ, Goldberger BA, Kolodner D, Fitzgerald K, Gold MS. Fentanyl and Propofol Exposure in the Operating Room: Sensitization Hypotheses and Further Data. Journal of Addictive Diseases 2008;27:67-76. [DOI: 10.1080/10550880802122661] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Earley PH, Finver T. Addiction to Propofol: A Study of 22 Treatment Cases. Journal of Addiction Medicine 2013;7:169-76. [DOI: 10.1097/adm.0b013e3182872901] [Cited by in Crossref: 30] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
2 Garcia-guasch R, Roigé J, Padrós J. Substance abuse in anaesthetists. Current Opinion in Anaesthesiology 2012;25:204-9. [DOI: 10.1097/aco.0b013e32834ef91b] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
3 Luo A, Zhang X, Li S, Zhao Y. Sevoflurane addiction due to workplace exposure: A case report and literature review. Medicine (Baltimore) 2018;97:e12454. [PMID: 30235733 DOI: 10.1097/MD.0000000000012454] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Thygesen MM, Rasmussen MM, Madsen JG, Pedersen M, Lauridsen H. Propofol (2,6-diisopropylphenol) is an applicable immersion anesthetic in the axolotl with potential uses in hemodynamic and neurophysiological experiments. Regeneration (Oxf) 2017;4:124-31. [PMID: 28975032 DOI: 10.1002/reg2.80] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
5 Shiraishi Zapata CJ. Anesthesiologists and Substance Use Disorders: An Important Issue for All Members of the Health Team. Anesth Analg 2015;120:1174. [PMID: 25899281 DOI: 10.1213/ANE.0000000000000647] [Reference Citation Analysis]
6 Zuleta-Alarcón A, Coffman JC, Soghomonyan S, Papadimos TJ, Bergese SD, Moran KR. Non-opioid anesthetic drug abuse among anesthesia care providers: a narrative review. Can J Anaesth 2017;64:169-84. [PMID: 27470230 DOI: 10.1007/s12630-016-0698-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
7 Kovacic P, Somanathan R. Clinical physiology and mechanism of dizocilpine (MK-801): electron transfer, radicals, redox metabolites and bioactivity. Oxid Med Cell Longev 2010;3:13-22. [PMID: 20716924 DOI: 10.4161/oxim.3.1.10028] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
8 Palhares Alves HN, Vieira DL, Laranjeira RR, Vieira JE, Nogueira Martins LA. Clinical and Demographic Profile of Anesthesiologists Using Alcohol and Other Drugs under Treatment in a Pioneering Program in Brazil. Brazilian Journal of Anesthesiology 2012;62:356-64. [DOI: 10.1016/s0034-7094(12)70136-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Merlo LJ, Greene WM. Physician views regarding substance use-related participation in a state physician health program. Am J Addict 2010;19:529-33. [PMID: 20958849 DOI: 10.1111/j.1521-0391.2010.00088.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
10 Cottler LB, Ajinkya S, Merlo LJ, Nixon SJ, Ben Abdallah A, Gold MS. Lifetime psychiatric and substance use disorders among impaired physicians in a physicians health program: comparison to a general treatment population: psychopathology of impaired physicians. J Addict Med 2013;7:108-12. [PMID: 23412081 DOI: 10.1097/ADM.0b013e31827fadc9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
11 Eckert PP, Finkelman M, Rosenberg MB. Prevalence of Substance Abuse Among Oral and Maxillofacial Surgery Residents From 2006 to 2015. J Oral Maxillofac Surg 2016;74:2351-8. [PMID: 27450751 DOI: 10.1016/j.joms.2016.06.176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
12 Oreskovich MR, Caldeiro RM. Anesthesiologists Recovering From Chemical Dependency: Can They Safely Return to the Operating Room? Mayo Clinic Proceedings 2009;84:576-80. [DOI: 10.4065/84.7.576] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
13 Xiong M, Shiwalkar N, Reddy K, Shin P, Bekker A. Neurobiology of Propofol Addiction and Supportive Evidence: What Is the New Development? Brain Sci 2018;8:E36. [PMID: 29470436 DOI: 10.3390/brainsci8020036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
14 Moonla C, Goud KY, Teymourian H, Tangkuaram T, Ingrande J, Suresh P, Wang J. An integrated microcatheter-based dual-analyte sensor system for simultaneous, real-time measurement of propofol and fentanyl. Talanta 2020;218:121205. [DOI: 10.1016/j.talanta.2020.121205] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
15 Merlo LJ, Greene WM, Pomm R. Mandatory naltrexone treatment prevents relapse among opiate-dependent anesthesiologists returning to practice. J Addict Med 2011;5:279-83. [PMID: 22107877 DOI: 10.1097/ADM.0b013e31821852a0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
16 Kovacic P. Unifying electron transfer mechanism for addiction involvement by the anesthetic propofol. Med Hypotheses 2010;74:206. [PMID: 19665852 DOI: 10.1016/j.mehy.2009.07.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
17 Oreskovich MR, Caldeiro RM. Anesthesiologists recovering from chemical dependency: can they safely return to the operating room? Mayo Clin Proc 2009;84:576-80. [PMID: 19567710 DOI: 10.1016/S0025-6196(11)60745-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]